TY - CONF
T1 - TWO-YEAR SURVIVAL WITH AXICABTAGENE CILOLEUCEL IN RELAPSED OR REFRACTORY LARGE B-CELL LYMPHOMA: AN UPDATED ANALYSIS
JO - HemaSphere
PY - 2019/06/26
AU - Diakite I
AU - Lin VW
AU - Klijn S
AU - Navale L
AU - Purdum AG
AU - Fenwick E
AU - Botteman M
AU - van Hout B
ED -
DO - DOI: 10.1097/01.hs9.0000565632.15112.c4
PB - Ovid Technologies (Wolters Kluwer Health)
VL - 3
SP - 817
EP - 817
Y2 - 2025/07/03
ER -